Coimbatore, India

Balaguru Murugesan

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Balaguru Murugesan: Innovator in Pharmaceutical Processes

Introduction

Balaguru Murugesan is a notable inventor based in Coimbatore, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug preparation. With a total of 2 patents to his name, Murugesan continues to impact the industry through his innovative approaches.

Latest Patents

Murugesan's latest patents include a process for the preparation of crystalline form I of methanesulfonate salt of dabigatran etexilate. This invention relates to a method that does not require the isolation of the dabigatran etexilate intermediate, streamlining the production process. Another significant patent involves the preparation of erlotinib and its pharmaceutically acceptable salts. This invention also introduces a novel crystalline form of erlotinib trifluoroacetate designated as Form E, along with processes for its preparation and conversion to erlotinib hydrochloride.

Career Highlights

Balaguru Murugesan is currently associated with Ranbaxy Laboratories, Inc., where he applies his expertise in pharmaceutical innovations. His work has been instrumental in advancing drug formulation techniques, contributing to the efficiency and effectiveness of pharmaceutical products.

Collaborations

Some of his notable coworkers include Anandam Vempali and Swargam Sathyanarayana, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion

Balaguru Murugesan's contributions to pharmaceutical processes exemplify the importance of innovation in drug development. His patents reflect a commitment to improving the efficiency of pharmaceutical manufacturing, ultimately benefiting the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…